InsiderLens

15 janv. 2026PURCHASESurrozen, Inc./DE5 59019.89 USD

indirect· By The Column Group III, LP

15 janv. 2026PURCHASESurrozen, Inc./DE6 30319.89 USD

indirect· By The Column Group III-A, LP

20 janv. 2026PURCHASESurrozen, Inc./DE9 56819.60 USD

indirect· By The Column Group III-A, LP

16 janv. 2026PURCHASESurrozen, Inc./DE1 35820.00 USD

indirect· By The Column Group III-A, LP

20 janv. 2026PURCHASESurrozen, Inc./DE8 48419.60 USD

indirect· By The Column Group III, LP

16 janv. 2026PURCHASESurrozen, Inc./DE1 20420.00 USD

indirect· By The Column Group III, LP

14 janv. 2026PURCHASESurrozen, Inc./DE2 92719.99 USD

indirect· By The Column Group III-A, LP

14 janv. 2026PURCHASESurrozen, Inc./DE2 59619.99 USD

indirect· By The Column Group III, LP

13 janv. 2026PURCHASESurrozen, Inc./DE5 86119.80 USD

indirect· By The Column Group III, LP

13 janv. 2026PURCHASESurrozen, Inc./DE6 60919.80 USD

indirect· By The Column Group III-A, LP

06 janv. 2026PURCHASESurrozen, Inc./DE8 00319.89 USD

indirect· By The Column Group III-A, LP

06 janv. 2026PURCHASESurrozen, Inc./DE7 09719.89 USD

indirect· By The Column Group III, LP

05 déc. 2025PURCHASESurrozen, Inc./DE16 38119.54 USD

indirect· By The Column Group III-A, LP

04 déc. 2025PURCHASESurrozen, Inc./DE2 79117.35 USD

indirect· By The Column Group III-A, LP

04 déc. 2025PURCHASESurrozen, Inc./DE2 47517.35 USD

indirect· By The Column Group III, LP

05 déc. 2025PURCHASESurrozen, Inc./DE14 50319.54 USD

indirect· By The Column Group III, LP

13 nov. 2025PURCHASESurrozen, Inc./DE167 30712.65 USD

indirect· By The Column Group III-A, LP1er après silence

13 nov. 2025PURCHASESurrozen, Inc./DE148 15012.65 USD

indirect· By The Column Group III, LP

26 mars 2025GRANT_AWARDSurrozen, Inc./DE2 6660.00 USD

détention directederiv

05 juin 2024GRANT_AWARDSurrozen, Inc./DE1 3330.00 USD

détention directederiv

04 avr. 2024PURCHASESurrozen, Inc./DE90 89715.50 USD

indirect· By The Column Group III, LP

04 avr. 2024PURCHASESurrozen, Inc./DE102 65115.50 USD

indirect· By The Column Group III-A, LP

05 avr. 2024OTHERNGM BIOPHARMACEUTICALS INC949 862—

indirect· See footnotes

05 avr. 2024OTHERNGM BIOPHARMACEUTICALS INC2 650 177—

indirect· See footnote

05 avr. 2024OTHERNGM BIOPHARMACEUTICALS INC90 442—

indirect· See footnote

Kutzkey Tim.

Kutzkey Tim.